LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes

Detalhes bibliográficos
Autor(a) principal: Bonyek-Silva, Icaro
Data de Publicação: 2021
Outros Autores: Machado, Antônio Fernando Araujo, Silva, Thiago Cerqueira, Nunes, Sara, Cruz, Marcio Rivison Silva, Silva, Jessica, Santos, Reinan Lima, Barral, Aldina Maria do Prado, Oliveira, Pablo Rafael Silveira, Khouri, Antonio Ricardo, Serezani, C. Henrique, Brodskyn, Claudia Ida, Caldas, Juliana Ribeiro, Barral Netto, Manoel, Boaventura, Viviane, Tavares, Natalia Machado
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/49900
Resumo: Inova Fiocruz/Fundac¸~ao Oswaldo Cruz to N.M.T. (VPPCB-005-FIO-20-2-75), Coordenac¸~ao de Aperfeic¸oamento de Pessoal de N ıvel Superior–Brazil (CAPES) under Finance Code 001 to I.B.-S., S.N., and J.S., Conselho Nacional de Desenvolvimento Cient ıfico e Tecnol ogico– Brazil (CNPq) (to I.B.-S., S.N., A.B., C.B., and M.B.-N.), and National Institutes of Health grants R01HL124159-01, DK122147-01A1 and AI149207A (to C.H.S.).
id CRUZ_d18db99d041090a5bdf2c78cbcf06014
oai_identifier_str oai:www.arca.fiocruz.br:icict/49900
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Bonyek-Silva, IcaroMachado, Antônio Fernando AraujoSilva, Thiago CerqueiraNunes, SaraCruz, Marcio Rivison SilvaSilva, JessicaSantos, Reinan LimaBarral, Aldina Maria do PradoOliveira, Pablo Rafael SilveiraKhouri, Antonio RicardoSerezani, C. HenriqueBrodskyn, Claudia IdaCaldas, Juliana RibeiroBarral Netto, ManoelBoaventura, VivianeTavares, Natalia Machado2021-11-19T19:54:47Z2021-11-19T19:54:47Z2021BONYEK-SILVA, Icaro et al. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes, v. 70, p. 2021-2130, Sept. 2021.0012-1797https://www.arca.fiocruz.br/handle/icict/4990010.2337/db20-1260Inova Fiocruz/Fundac¸~ao Oswaldo Cruz to N.M.T. (VPPCB-005-FIO-20-2-75), Coordenac¸~ao de Aperfeic¸oamento de Pessoal de N ıvel Superior–Brazil (CAPES) under Finance Code 001 to I.B.-S., S.N., and J.S., Conselho Nacional de Desenvolvimento Cient ıfico e Tecnol ogico– Brazil (CNPq) (to I.B.-S., S.N., A.B., C.B., and M.B.-N.), and National Institutes of Health grants R01HL124159-01, DK122147-01A1 and AI149207A (to C.H.S.).This work was supported by the Inova Fiocruz/Fundação Oswaldo Cruz to N.M.T. (VPPCB-005-FIO-20-2-75), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brazil (CAPES) under Finance Code 001 to I.B.-S., S.N., and J.S., Conselho Nacional de Desenvolvimento Cientıfico e Tecnologico–Brazil (CNPq) (to I.B.-S., S.N., A.B., C.B., and M.B.-N.), and National Institutes of Health grants R01HL124159-01, DK122147-01A1 and AI149207A (to C.H.S.).Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Salvador University. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Salvador University. Salvador, BA, Brazil / Ernesto Simões Filho Hospital. Critical Care Unit. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Pharmacy School. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil / National Institute of Science and Technology. Institute of Investigation in Immunology. São Paulo, SP, Brazil.Federal University of Bahia. Institute of Biological Sciences. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Vanderbilt University. Department of Medicine. Division of Infectious Diseases. Medical Center. Nashville, TN, USA.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil / National Institute of Science and Technology. Institute of Investigation in Immunology. São Paulo, SP, Brazil.Salvador University. Salvador, BA, Brazil / Ernesto Simões Filho Hospital. Critical Care Unit. Salvador, BA, Brazil / São Rafael Hospital–Rede d’Or. Critical Care Unit. Salvador, BA, Brazil / Bahiana School of Medicine and Public Health. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil / National Institute of Science and Technology. Institute of Investigation in Immunology. São Paulo, SP, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil.Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Salvador, BA, Brazil / Federal University of Bahia. Medical School. Salvador, BA, Brazil / National Institute of Science and Technology. Institute of Investigation in Immunology. São Paulo, SP, Brazil.Diabetes is a known risk factor for severe coronavirus disease 2019 (COVID-19), the disease caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is a lack of knowledge about the mechanisms involved in the evolution of COVID-19 in individuals with diabetes. We aimed to evaluate whether the chronic low-grade inflammation of diabetes could play a role in the development of severe COVID-19. We collected clinical data and blood samples of patients with and without diabetes hospitalized for COVID-19. Plasma samples were used to measure inflammatory mediators and peripheral blood mononuclear cells, for gene expression analysis of the SARS-CoV-2 main receptor system (ACE2/TMPRSS2), and for the main molecule of the leukotriene B4 (LTB4) pathway (ALOX5). We found that diabetes activates the LTB4 pathway and that during COVID-19 it increases ACE2/TMPRSS2 as well as ALOX5 expression. Diabetes was also associated with COVID-19–related disorders, such as reduced oxygen saturation as measured by pulse oximetry/fraction of inspired oxygen (FiO2) and arterial partial pressure of oxygen/FiO2 levels, and increased disease duration. In addition, the expressions of ACE2 and ALOX5 are positively correlated, with increased expression in patients with diabetes and COVID-19 requiring intensive care assistance. We confirmed these molecular results at the protein level, where plasma LTB4 is significantly increased in individuals with diabetes. In addition, IL-6 serum levels are increased only in individuals with diabetes requiring intensive care assistance. Together, these results indicate that LTB4 and IL-6 systemic levels, as well as ACE2/ALOX5 blood expression, could be early markers of severe COVID-19 in individuals with diabetes.engAmerican Diabetes AssociationSARS-CoV-2Síndrome Respiratória Aguda GraveCoronavirusDiabetesInflamaçãoSARS-CoV-2Severe Acute Respiratory SyndromeCoronavirusDiabetesInflammationLTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83097https://www.arca.fiocruz.br/bitstream/icict/49900/1/license.txt36b51ef91c52b5338d9d29ba0cc807bcMD51ORIGINALSilva, Icaro Bonyek LTB4 - Driven....pdfSilva, Icaro Bonyek LTB4 - Driven....pdfapplication/pdf1969170https://www.arca.fiocruz.br/bitstream/icict/49900/2/Silva%2c%20Icaro%20Bonyek%20LTB4%20-%20Driven....pdf92d939ce144dd66a78f89db5fe9819b0MD52icict/499002023-03-15 14:34:32.012oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:32Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
title LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
spellingShingle LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
Bonyek-Silva, Icaro
SARS-CoV-2
Síndrome Respiratória Aguda Grave
Coronavirus
Diabetes
Inflamação
SARS-CoV-2
Severe Acute Respiratory Syndrome
Coronavirus
Diabetes
Inflammation
title_short LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
title_full LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
title_fullStr LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
title_full_unstemmed LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
title_sort LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
author Bonyek-Silva, Icaro
author_facet Bonyek-Silva, Icaro
Machado, Antônio Fernando Araujo
Silva, Thiago Cerqueira
Nunes, Sara
Cruz, Marcio Rivison Silva
Silva, Jessica
Santos, Reinan Lima
Barral, Aldina Maria do Prado
Oliveira, Pablo Rafael Silveira
Khouri, Antonio Ricardo
Serezani, C. Henrique
Brodskyn, Claudia Ida
Caldas, Juliana Ribeiro
Barral Netto, Manoel
Boaventura, Viviane
Tavares, Natalia Machado
author_role author
author2 Machado, Antônio Fernando Araujo
Silva, Thiago Cerqueira
Nunes, Sara
Cruz, Marcio Rivison Silva
Silva, Jessica
Santos, Reinan Lima
Barral, Aldina Maria do Prado
Oliveira, Pablo Rafael Silveira
Khouri, Antonio Ricardo
Serezani, C. Henrique
Brodskyn, Claudia Ida
Caldas, Juliana Ribeiro
Barral Netto, Manoel
Boaventura, Viviane
Tavares, Natalia Machado
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bonyek-Silva, Icaro
Machado, Antônio Fernando Araujo
Silva, Thiago Cerqueira
Nunes, Sara
Cruz, Marcio Rivison Silva
Silva, Jessica
Santos, Reinan Lima
Barral, Aldina Maria do Prado
Oliveira, Pablo Rafael Silveira
Khouri, Antonio Ricardo
Serezani, C. Henrique
Brodskyn, Claudia Ida
Caldas, Juliana Ribeiro
Barral Netto, Manoel
Boaventura, Viviane
Tavares, Natalia Machado
dc.subject.other.pt_BR.fl_str_mv SARS-CoV-2
Síndrome Respiratória Aguda Grave
Coronavirus
Diabetes
Inflamação
topic SARS-CoV-2
Síndrome Respiratória Aguda Grave
Coronavirus
Diabetes
Inflamação
SARS-CoV-2
Severe Acute Respiratory Syndrome
Coronavirus
Diabetes
Inflammation
dc.subject.en.pt_BR.fl_str_mv SARS-CoV-2
Severe Acute Respiratory Syndrome
Coronavirus
Diabetes
Inflammation
description Inova Fiocruz/Fundac¸~ao Oswaldo Cruz to N.M.T. (VPPCB-005-FIO-20-2-75), Coordenac¸~ao de Aperfeic¸oamento de Pessoal de N ıvel Superior–Brazil (CAPES) under Finance Code 001 to I.B.-S., S.N., and J.S., Conselho Nacional de Desenvolvimento Cient ıfico e Tecnol ogico– Brazil (CNPq) (to I.B.-S., S.N., A.B., C.B., and M.B.-N.), and National Institutes of Health grants R01HL124159-01, DK122147-01A1 and AI149207A (to C.H.S.).
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-11-19T19:54:47Z
dc.date.available.fl_str_mv 2021-11-19T19:54:47Z
dc.date.issued.fl_str_mv 2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BONYEK-SILVA, Icaro et al. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes, v. 70, p. 2021-2130, Sept. 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/49900
dc.identifier.issn.pt_BR.fl_str_mv 0012-1797
dc.identifier.doi.none.fl_str_mv 10.2337/db20-1260
identifier_str_mv BONYEK-SILVA, Icaro et al. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes, v. 70, p. 2021-2130, Sept. 2021.
0012-1797
10.2337/db20-1260
url https://www.arca.fiocruz.br/handle/icict/49900
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Diabetes Association
publisher.none.fl_str_mv American Diabetes Association
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/49900/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/49900/2/Silva%2c%20Icaro%20Bonyek%20LTB4%20-%20Driven....pdf
bitstream.checksum.fl_str_mv 36b51ef91c52b5338d9d29ba0cc807bc
92d939ce144dd66a78f89db5fe9819b0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008912208625664

Registros relacionados